- Report
- March 2025
- 182 Pages
Global
From €3228EUR$3,545USD£2,776GBP
€3587EUR$3,939USD£3,085GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$4,117USD£3,115GBP
- Report
- April 2024
- 114 Pages
Global
From €3500EUR$4,117USD£3,115GBP
- Report
- March 2025
- 114 Pages
Global
From €3500EUR$4,117USD£3,115GBP
- Report
- April 2025
- 50 Pages
Global
From €2413EUR$2,650USD£2,075GBP
- Report
- November 2021
- 844 Pages
Global
From €4553EUR$5,000USD£3,916GBP
Citicoline is a drug used to treat neurological disorders, such as stroke, Alzheimer's disease, and Parkinson's disease. It is a naturally occurring compound found in the brain and is believed to help protect and repair neurons. It is also used to improve cognitive function, memory, and concentration. Citicoline is available in both oral and intravenous forms.
Citicoline is a relatively new drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological disorders, and is believed to have potential for treating other CNS disorders. It is also being studied for its potential to improve cognitive function and memory.
The CNS drug market is a rapidly growing market, with many companies developing new drugs to treat neurological disorders. Companies such as Pfizer, Merck, and Novartis are leading the way in developing new CNS drugs. Other companies such as Allergan, GlaxoSmithKline, and Sanofi are also developing new CNS drugs, including citicoline. Show Less Read more